Figure 2.
Clinical trials evaluating nontransplant approaches for primary refractory and first relapsed cHL. ISRT, involved site radiation therapy; Pembro-RT, pembrolizumab plus radiation therapy.
Clinical trials evaluating nontransplant approaches for primary refractory and first relapsed cHL. ISRT, involved site radiation therapy; Pembro-RT, pembrolizumab plus radiation therapy.